blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1551876

EP1551876 - ANTIBODIES THAT BIND CELL-ASSOCIATED CA 125/0722P AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.01.2012
Database last updated on 03.08.2024
Most recent event   Tooltip20.01.2012No opposition filed within time limitpublished on 22.02.2012  [2012/08]
Applicant(s)For all designated states
Purdue Pharma L.P.
One Stamford Forum 201 Tresser Boulevard
Stamford, CT 06901-3431 / US
[2010/32]
Former [2008/23]For all designated states
EURO-CELTIQUE S.A.
2, avenue Charles de Gaulle
1653 Luxembourg / LU
Former [2005/28]For all designated states
Euro-Celtique S.A.
122 Boulevard de la Pétrusse
2330 Luxembourg / LU
Inventor(s)01 / ALBONE, Earl, F.
1766 Sheffield Dr.
Blue Bell, PA 19422 / US
02 / SOLTIS, Daniel, A.
7 Shetland Green
Belle Mead, NJ 08502 / US
 [2005/28]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2005/28]Maiwald Patentanwalts GmbH
Elisenhof, Elisenstrasse 3
80335 München / DE
Application number, filing date03789713.915.10.2003
[2005/28]
WO2003US32945
Priority number, dateUS20020418828P16.10.2002         Original published format: US 418828 P
US20030485986P10.07.2003         Original published format: US 485986 P
[2005/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004035537
Date:29.04.2004
Language:EN
[2004/18]
Type: A2 Application without search report 
No.:EP1551876
Date:13.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 29.04.2004 takes the place of the publication of the European patent application.
[2005/28]
Type: B1 Patent specification 
No.:EP1551876
Date:16.03.2011
Language:EN
[2011/11]
Search report(s)International search report - published on:US04.11.2004
(Supplementary) European search report - dispatched on:EP28.10.2005
ClassificationIPC:C07K16/00, A61K39/395, C12N5/12, C07H21/04, G01N33/53
[2005/28]
CPC:
C07K16/3069 (EP,US); C07K16/30 (KR); A61K39/395 (KR);
A61K47/6869 (EP,US); A61P11/00 (EP); A61P15/00 (EP);
A61P15/08 (EP); A61P35/00 (EP); A61P43/00 (EP);
C07K16/28 (KR); A61K2039/505 (EP,US); C07K2317/56 (EP,US);
C07K2317/565 (EP,US); C07K2317/732 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/28]
Extension statesAL13.04.2005
LT13.04.2005
LV13.04.2005
MK13.04.2005
TitleGerman:ANTIKÖRPER, DIE AN ZELLASSOZIIERTES CA 125/0722P BINDEN, UND VERFAHREN ZU DEREN ANWENDUNG[2005/28]
English:ANTIBODIES THAT BIND CELL-ASSOCIATED CA 125/0722P AND METHODS OF USE THEREOF[2005/28]
French:ANTICORPS SE FIXANT SUR DES POLYPEPTIDES CA 125/0722P ASSOCIES A DES CELLULES ET LEURS PROCEDES D'UTILISATION[2005/28]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase13.04.2005National basic fee paid 
13.04.2005Search fee paid 
13.04.2005Designation fee(s) paid 
13.04.2005Examination fee paid 
Examination procedure14.05.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
13.04.2005Amendment by applicant (claims and/or description)
13.04.2005Examination requested  [2005/28]
12.01.2006Despatch of a communication from the examining division (Time limit: M06)
24.07.2006Reply to a communication from the examining division
28.06.2007Despatch of a communication from the examining division (Time limit: M06)
13.02.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.04.2008Reply to a communication from the examining division
10.02.2009Despatch of a communication from the examining division (Time limit: M04)
18.06.2009Reply to a communication from the examining division
22.09.2009Communication of intention to grant the patent
19.01.2010Fee for grant paid
19.01.2010Fee for publishing/printing paid
Divisional application(s)EP10160744.8  / EP2298806
EP10178547.5  / EP2301965
EP15155786.5  / EP2891666
EP17177795.6  / EP3301114
Opposition(s)19.12.2011No opposition filed within time limit [2012/08]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
22.04.2008Request for further processing filed
22.04.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
07.10.2005Renewal fee patent year 03
05.10.2006Renewal fee patent year 04
15.10.2007Renewal fee patent year 05
07.10.2008Renewal fee patent year 06
26.10.2009Renewal fee patent year 07
23.09.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5976818  (O'BRIEN TIMOTHY J [US]) [A] 1-70* the whole document *;
 [X]WO0036107  (CORIXA CORP [US]) [X] 65 * the whole document *;
 [E]WO2004005470  (IMMUNOGEN INC [US]) [E] 1-7,9-14,16,28-38,40,52-61,63,65-68,70 * the whole document *;
 [X]  - NUSTAD K ET AL, "Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: First report from the ISOBM TD-1 workshop", TUMOR BIOLOGY, (1996), vol. 17, no. 4, ISSN 1010-4283, pages 196 - 219, XP009054890 [X] 16,63 * abstract *
 [X]  - NAP M ET AL, "IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL ANTIBODIES AGAINST THE CA125 ANTIGEN: 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP", TUMOR BIOLOGY, KARGER, BASEL, CH, (1996), vol. 17, no. 6, ISSN 1010-4283, pages 325 - 331, XP008037327 [X] 16,63 * the whole document *
 [A]  - O'BRIEN TIMOTHY J ET AL, "The CA 125 gene: An extracellular superstructure dominated by repeat sequences", TUMOR BIOLOGY, (200111), vol. 22, no. 6, ISSN 1010-4283, pages 348 - 366, XP002953298 [A] 1-70 * the whole document *

DOI:   http://dx.doi.org/10.1159/000050638
International search[Y]US5693762  (QUEEN CARY L [US], et al);
 [X]WO0206317  (CORIXA CORP [US], et al)
Examination   - SINGLETON J. ET AL, "Characterization of antibodies to CA-125 that bind preferentially to the cell-associtaed form of the antigen", TUMOR BIOLOGY, (2006), vol. 27, page 122-132
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.